Thrombopoietin Agonists in Patients With Idiopathic Thrombocytopenic Purpura

ConditionITP - Immune Thrombocytopenia

Trial statusNot yet recruiting

Trial phaseNot listed

Trial typeObservational

Biological sexAll

Age18-75

SponsorAssiut University

About this trial

1. Assesement of response to Thrombopoietin receptor agonists (TPO-RAs) as treatment in Idiopathic thrombocytopenia purpura patients in Assiut University hospital. 2. Explore side effects of Thrombopoietin receptor agonists in Idiopathic thrombocytopenia purpura . 3. To study effect of thrombopoietin receptor agonists and Quality life in Idiopathic thrombocytopenia purpura patients.

Eligibility criteria

This trial does not accept healthy volunteers

Qualifiers

Patients presented with Idiopathic thrombocytopenic purpura (ITP)

patients above age of 18 years.

Disqualifiers

patients below age of 18 years .

Trial population

Patients presented with Idiopathic thrombocytopenic purpura ( ITP) at clinical Hematology units, Internal Medicine Department at Assiut University . Patients above age of 18 years.

Trial design

Design model

Cohort

Time perspective

Prospective

Treatments tested in this trial

eltrombopag and romiplastim
Drug
Group I: eltrombopag and romiplastim Group II : recived corticosteroid.

Treatment groups

100 Participants

are divided into 2 treatment groups

Group A: Group 11 intervention

Group B: Group 21 intervention

Trial outcomes

Primary outcomes

Assessment of response to treatment will be clinical and laboratory assessment

Platelet count should be measured weekly until a stable platelet count that is associated with an absence of bleeding symptoms is achieved for 4 weeks without adjustment and then measured monthly thereafter.

Time frame

Baseline

Locations

This trial has no locations.

Sponsors and contacts

Click on the lead sponsor to view all of their trials.

Assiut University

Lead sponsor

Association for Training, Education, and Research in Hematology, Immunology, and Transplantation

Collaborator

Source ClinicalTrials.gov

This trial is not recruiting at the moment. You can still explore other options: